RCAG
IMUC

Rehmann Capital Advisory Group’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Rehmann Capital Advisory Group’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-69
Closed -$14 – 2271
2018
Q3 		$14 Hold
69
– – ﹤0.01% 2127
2018
Q2 		$18 Buy
+69
New +$18 ﹤0.01% 2104

Other funds holding IMUC

WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return